India’s Contract Research, Development, and Manufacturing Organization industry is set to double to US$ 14 billion by 2028, driven by pharma outsourcing, regulatory support, and global supply chain ...

The U.S. Senate confirmed Robert F. Kennedy Jr. as the Secretary of the Department of Health and Human Services on ...

A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds.

According to the Southern Shrimp Alliance (SSA), U.S. Food and Drug Administration (FDA) refusals of foreign shrimp for ...

Sanofi Healthcare India receives marketing authorization for Rezurock, a new treatment for chronic graft-versus-host disease ...